Opaleye Management Inc. Insider Trading $ETON Eton Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Opaleye Management Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Opaleye Management Inc.. Opaleye Management Inc. is 10% Owner in Protara Therapeutics, Inc. ($TARA) and 10% Owner in Imprimis Pharmaceuticals, Inc. ($IMMY) and 10% Owner in OCULAR THERAPEUTIX, INC ($OCUL) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Eton Pharmaceuticals, Inc. ($ETON).
Opaleye Management Inc. in Eton Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Opaleye Management Inc.: 10% Owner
Holdings: 3,839,000 shares
Latest Transaction: May 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Opaleye Management Inc. in Eton Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETON, HROW, OCUL, TARA, TCON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.49 | 4,600 | 39,054 | 145,600 | 150.2 K to 145.6 K (-3.06 %) |
| May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.49 | 121,400 | 1,030,686 | 3,652,100 | 3.8 M to 3.7 M (-3.22 %) |
| May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.57 | 2,800 | 23,996 | 150,200 | 153 K to 150.2 K (-1.83 %) |
| May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.57 | 65,500 | 561,335 | 3,773,500 | 3.8 M to 3.8 M (-1.71 %) |
| May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.53 | 2,000 | 17,060 | 153,000 | 155 K to 153 K (-1.29 %) |
| May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.53 | 46,000 | 392,380 | 3,839,000 | 3.9 M to 3.8 M (-1.18 %) |
| Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 15,000 | 105,000 | 155,000 | 140 K to 155 K (+10.71 %) |
| Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 15,000 | 105,000 | 155,000 | 140 K to 155 K (+10.71 %) |
| Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 385,000 | 2,695,000 | 3,885,000 | 3.5 M to 3.9 M (+11.00 %) |
| Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 385,000 | 2,695,000 | 3,885,000 | 3.5 M to 3.9 M (+11.00 %) |
Page: 1